Potential Drug Target and Biomarker for RPL36 (G25873)

Target Name: RPL36

NCBI ID: G25873

RPL36

Potential Drug Target and Biomarker for RPL36

RPL36 (regeneration-promoting protein 36) is a protein that has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. RPL36 is a member of the RPL36 family, which is known for its role in cell regeneration and plasticity. In this article, we will explore the biology of RPL36 and its potential as a drug target.

History of RPL36

The RPL36 protein was first identified in 2004 by researchers at the University of California, San Diego as a protein that was expressed in a variety of tissues, including brain, muscle, and heart. The protein was shown to be involved in the regulation of cell proliferation and differentiation, as well as in the process of cell regeneration.

Since its initial identification, numerous studies have further characterized the biology of RPL36. These studies have shown that RPL36 is involved in a variety of cellular processes, including cell proliferation, apoptosis, migration, and invasion. RPL36 has also been shown to play a role in the regulation of cell-cell adhesion, as well as in the formation of tissues and organs during development and regeneration.

Drug Target Potential

RPL36 has been identified as a potential drug target due to its involvement in various cellular processes that are associated with disease. One of the main reasons for its potential as a drug target is its involvement in cell proliferation and differentiation. RPL36 has been shown to play a role in the regulation of cell proliferation, and it has been shown to promote the growth and differentiation of various cell types.

In addition to its role in cell proliferation and differentiation, RPL36 is also involved in the regulation of cell apoptosis, or cell death. Studies have shown that RPL36 can induce cell apoptosis in a variety of cell types, and that this process is regulated by various factors, including the availability of oxygen and nutrients.

Another potential drug target for RPL36 is its role in the regulation of cell migration and invasion. Studies have shown that RPL36 can promote the migration and invasion of various cell types, and that this process is regulated by various factors, including the availability of signaling molecules and the presence of mechanical forces.

In addition to its role in cell proliferation, differentiation, and migration, RPL36 is also involved in the regulation of cell-cell adhesion. Studies have shown that RPL36 can interact with various cell-cell adhesion molecules, including cadherins and integrins, and that this interaction plays a role in the regulation of cell-cell adhesion.

Biomarker Potential

RPL36 has also been identified as a potential biomarker for several diseases. For example, studies have shown that RPL36 is involved in the regulation of cell proliferation and differentiation, and that this process is disrupted in various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

In addition to its involvement in disease processes, RPL36 has also been shown to be involved in the regulation of cellular processes that are healthy and normal. For example, studies have shown that RPL36 is involved in the regulation of cell proliferation and differentiation during development and regeneration, as well as in the regulation of cell apoptosis.

Conclusion

In conclusion, RPL36 is a protein that has been identified as a potential drug target and biomarker for a variety of diseases. Its involvement in the regulation of cell proliferation, differentiation, migration, and adhesion, as well as its involvement in the regulation of cell apoptosis, make RPL36 a promising candidate for drug development. Further research is needed to fully understand the biology of RPL36 and its potential as a drug target and biomarker.

Protein Name: Ribosomal Protein L36

Functions: Component of the large ribosomal subunit (PubMed:12962325, PubMed:23636399, PubMed:25901680, PubMed:25957688, PubMed:32669547). The ribosome is a large ribonucleoprotein complex responsible for the synthesis of proteins in the cell (PubMed:12962325, PubMed:23636399, PubMed:25901680, PubMed:25957688, PubMed:32669547)

The "RPL36 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RPL36 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets